• HOME
  • ABOUT US+
    • CAREERS
  • SPECIALTIES+
    • Rheumatology
    • Gastroenterologists
    • Neurologists
    • Pulmonology, Allergy and ENT
  • SERVICES+
    • Billing and Reimbursement Solutions
    • Buy and Bill Education
    • Clinical Staffing & training Services
    • Compliance & Regulatory Guidance
    • In-Office Infusion Suite Setup
    • Patient Access & Financial Assistance Services
    • Specialty Medication Coordination & Procurement
    • Specialty Program Implementation
    • Technology & Workflow Optimization for Infusion Therapy
  • BLOG+
  • EVENTS
  • CONTACT US
Fall Allergies or Something More? Understanding Chronic Sinusitis and Biologic Treatment Options

Fall Allergies or Something More?

Relieving the Bottleneck: Helping Providers Accelerate Patient Access to Biologic Therapies

Relieving the Bottleneck: Helping Providers Accelerate Patient Access to Biologic Therapies

Flare-Proof Fall: Managing Autoimmune Conditions as Temperatures Drop

Flare-Proof Fall: Managing Autoimmune Conditions as Temperatures Drop

A quiet but significant change is coming to the 340B Program, and it could reshape the way your practice manages high-cost specialty drugs. Starting in 2026, the Department of Health and Human Services (HHS) will test a new Rebate Model Pilot that lets drug manufacturers offer rebates instead of the traditional upfront discounts on certain 340B drugs. At first glance, this might sound like a technical policy shift. However, for specialty practices like yours, it could mean new financial pressures, administrative headaches, and cash flow challenges. Let’s break down what’s changing, why it matters, and how you can prepare.

The 340B Rebate Pilot Is Coming: What Providers Need to Know About the Shift from Discounts to Rebates

Biologics and the Bottom Line: Understanding Your Real Costs — and How to Manage Them

Biologics and the Bottom Line: Understanding Your Real Costs

Biologics vs. Traditional Treatments: What’s the Difference and Why It Matters for Your Long-Term Health

Biologics vs. Traditional Treatments: What’s the Difference and Why It Matters for Your Long-Term Health

Improving Patient Retention in Biologic Therapy: Strategies to Address Fear, Fatigue, and Follow-Through

Improving Patient Retention in Biologic Therapy

Heading Back to Class or Campus with a Chronic Illness: A Biologics Readiness Checklist

Heading Back to Class or Campus with a Chronic Illness: A Biologics Readiness Checklist

Streamlining Patient Access: How In-Office Biologic Administration Improves Adherence and Outcomes in Severe Asthma Care

Streamlining Patient Access: How In-Office Biologic Administration Improves Adherence and Outcomes in Severe Asthma Care

Summer Travel When Living with Multiple Sclerosis: Staying Cool, Safe, and on Schedule

1 2 3 4 … 34 Next

Subscribe For Newsletter

Error: Contact form not found.

Altus Biologics delivers comprehensive in-office biologic therapy solutions tailored to specialty practices. Subscribe to our newsletter today.

Altus Biologics delivers comprehensive in-office infusion and biologic therapy solutions tailored to specialty practices.

11233 Shadow Creek Parkway, Suite 303, Pearland, TX 77584, USA
info@altusbiologics.com
+1 855.692.5887

Quick Link

  • Optimizing In-Office Biologics Therapy Solutions
  • Careers
  • Services
  • Contact
  • Blog

Recent Post

Fall Allergies or Something More? Understanding Chronic Sinusitis and Biologic Treatment Options

Fall Allergies or Something More?

5 days ago
Relieving the Bottleneck: Helping Providers Accelerate Patient Access to Biologic Therapies

Relieving the Bottleneck: Helping Providers Accelerate Patient Access to Biologic Therapies

7 days ago
11233 Shadow Creek Parkway, Suite 303, Pearland, TX 77584, USA
info@altusbiologics.com
+1 855.692.5887

Copyright 2025 Altus Biologics All Rights Reserved.

Facebook
X
Instagram
LinkedIn